Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

IKT holding history

Inhibikase Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IKT overviewAll 13F holders of IKTFull Q2 2026 holdings

Shares (Q2 2026)
114,006
Value
$231.4K
% of portfolio
<0.1%
Quarters held
18
Since Q4 2021
Holdings of IKT by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026114,006$231.4K<0.1%−50,253−30.6%ReducedHolders
Q1 2026164,259$276.0K<0.1%+84,577+106.1%AddedHolders
Q4 202579,682$163.3K<0.1%+23,663+42.2%AddedHolders
Q3 202556,019$90.8K<0.1%−43,659−43.8%ReducedHolders
Q2 202599,678$194.4K<0.1%+78,032+360.5%AddedHolders
Q1 202521,646$47.4K<0.1%+14,350+196.7%AddedHolders
Q4 20247,296$23.7K<0.1%+5,629+337.7%AddedHolders
Q3 20241,667$2.17K<0.1%00.0%UnchangedHolders
Q2 20241,667$2.02K<0.1%00.0%UnchangedHolders
Q1 20241,667$3.60K<0.1%00.0%UnchangedHolders
Q4 20231,667$2.12K<0.1%00.0%UnchangedHolders
Q3 20231,667$2.32K<0.1%00.0%UnchangedHolders
Q2 20231,667$6.02K<0.1%00.0%UnchangedConverted for a 1-for-6 splitHolders
Q1 202310,000$6.58K<0.1%00.0%UnchangedHolders
Q4 202210,000$5.00K<0.1%00.0%UnchangedHolders
Q3 202210,000$9.00K<0.1%00.0%UnchangedHolders
Q2 202210,000$7.00K<0.1%+10,000NewHolders
Q1 20220$00.0%−2−100.0%Sold outHolders
Q4 20212$00.0%+2NewHolders